Pertussis (whooping cough)

  • 2024/06 - Recommendations (Pdf, 54 Kb) on the immunisation of pregnant women (against whooping cough and influenza)

    The Superior Council of Infectious Diseases (Conseil supérieur des maladies infectieuses - CSMI) recommends vaccinating women who are in their second or third trimester of pregnancy with the DTaP vaccine, or the DTaP-IPV vaccine. To maximise its effectiveness, the vaccine should ideally be administered during the second trimester (between the 13th and 26th week of gestation), but it can also be administered up to the 36th week (or 2 weeks before the birth at the latest).
  • 2024/02 - Recommendations (Pdf, 870 Kb) in response to the increase in the number of cases of whooping cough in Luxembourg: prevention strategy
  • 2023/12 - Recommendations (Pdf, 1023 Kb) on the 2024 vaccination schedule

    March 2024 update, with corrections and clarifications in Part B. Overview of recommended vaccinations
  • 2019/12 - Recommendations (Pdf, 784 Kb) on the vaccination of babies born prematurely

    The Superior Council of Infectious Diseases recommends vaccinating babies born prematurely (i.e. before 37 weeks of amenorrhoea): 1) depending on the child's age 2) by supplementing the universal vaccination schedule with an additional dose: 2.1.) of pneumococcal conjugate vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies < 33 weeks, or < 1,500 g; 2.2.) of hepatitis B vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies < 2,000 g; 3) by supplementing the universal vaccination schedule with: 3.1.) a seasonal influenza vaccine dose, for premature babies < 33 weeks, for the first two winter seasons; 3.2.) RSV (respiratory syncytial virus) immunisation, for premature babies who are at risk during the winter season. In addition, the CSMI recommends checking and updating the vaccination status of those in the premature baby's family circle – especially as regards whooping cough – and vaccinating them against seasonal influenza during the child's first two winters.

  • 2017/10 - Recommendations (Pdf, 477 Kb) on the immunisation of adults against DIPHTHERIA, TETANUS, WHOOPING COUGH and POLIOMYELITIS

  • 2006/05 - Recommendations (Pdf, 28 Kb) on the immunisation of adolescents and adults against whooping cough

    An increase in the number of cases of whooping cough has been observed in Europe. As this is tied to the progressive decline in the protective immunity afforded by vaccination after five to 10 years, adolescents and adults are the most affected populations. As such, the CSMI recommends introducing DTaP-IPV vaccination for adolescents and adults, in the form of a single injection administered every 10 years from the age of 15. The combined DTaP-IPV vaccine replaces the DT-IPV, which is currently used, but which is no longer recommended as a booster in adults. In addition to these recommendations, this document contains information on the following topics: clinical signs of Bordetella infection, discussion, and conclusions.

CSMI: Factsheet on vaccination of pregnant women (recommendation dated 26 June 2024)

Last update